4.7 Review

Mitochondrial DNA and disease

期刊

JOURNAL OF PATHOLOGY
卷 226, 期 2, 页码 274-286

出版社

WILEY-BLACKWELL
DOI: 10.1002/path.3028

关键词

mitochondrion; oxidative phosphorylation; disease; mitochondrial DNA; mutation

资金

  1. Newcastle University Centre for Brain Ageing and Vitality
  2. BBSRC
  3. EPSRC
  4. ESRC
  5. MRC [G0700718]
  6. Wellcome Trust [074454/Z/04/Z]
  7. UK NIHR Biomedical Research Centre for Ageing and Age-related Disease
  8. UK NHS Specialist Commissioners
  9. MRC [G0601943, G0400074, G1100540, G0900652, G0502157] Funding Source: UKRI
  10. Medical Research Council [G0900652, G0700718, G0601943, G0502157, G0400074, G1100540] Funding Source: researchfish
  11. National Institute for Health Research [NF-SI-0510-10187] Funding Source: researchfish

向作者/读者索取更多资源

Mitochondrial DNA (mtDNA) defects are a relatively common cause of inherited disease and have been implicated in both ageing and cancer. MtDNA encodes essential subunits of the mitochondrial respiratory chain and defects result in impaired oxidative phosphorylation (OXPHOS). Similar OXPHOS defects have been shown to be present in a number of neurodegenerative conditions, including Parkinson's disease, as well as in normal ageing human tissues. Additionally, a number of tumours have been shown to contain mtDNA mutations and an altered metabolic phenotype. In this review we outline the unique characteristics of mitochondrial genetics before detailing important pathological features of mtDNA diseases, focusing on adult neurological disease as well as the role of mtDNA mutations in neurodegenerative diseases, ageing and cancer. Copyright (C) 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据